PRINT THIS PAGE GTCR Golder Rauner sells Curascript for $335m23/12/2003. Source: AltAssets. 
 US private equity firm GTCR Golder Rauner has exited its investment in Curascript Pharmacy. The firm has sold Curascript to publicly traded Express Scripts for approximately $335m.
Curascript is the largest privately held speciality pharmacy services company in the US and was formed in 2000 through the management led buy-out of Coram Prescription Services worth $41.3m.
‘Our investment in Curascript exemplifies the success of the GTCR strategy of proactively identifying growth industries and then finding and backing excellent executives in those industries,’ said GTCR principal Ethan Budin.
GTCR was founded in 1980 and currently has more than $6bn under management. Its investment focus includes the transaction processing and payments services, communication services, information technology services, healthcare services, and outsourced business services sectors.
Copyright © 2003 AltAssets
|
